| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/05/2010 | US7807412 Using platelete derived growth fator as tool in detection of modulators for prevention and treatment of cell proliferative disorders |
| 10/05/2010 | US7807191 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| 10/05/2010 | US7807179 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders |
| 10/05/2010 | US7807142 comprising interleukin-2 (IL-2); using an amino acid base sufficient to decrease aggregate formation of the polypeptide during storage of the composition, and a buffering agent ; mixture with amino acid and buffer |
| 10/05/2010 | CA2506803C Functional domain and associated molecule of dock2 essentially required in lymphocyte migration |
| 10/05/2010 | CA2428662C Small acid-soluble spore protein and uses thereof |
| 10/05/2010 | CA2407967C Tubulin binding ligands and corresponding prodrug constructs |
| 10/05/2010 | CA2400479C Platelet adp receptor inhibitors |
| 10/05/2010 | CA2393297C Polyhydroxystilbenes as antipsoriatic agents and protein kinase inhibitors |
| 10/05/2010 | CA2391161C Pharmaceutical combinations comprising a p2t receptor antagonist and an anti-thrombotic agent |
| 09/30/2010 | WO2010110479A1 Activator for peroxisome proliferator-activated receptor |
| 09/30/2010 | WO2010110440A1 Novel therapeutic agent for cognitive impairment |
| 09/30/2010 | WO2010110436A1 Matrix-type sustained release preparation containing basic additive |
| 09/30/2010 | WO2010110400A1 Heterocyclic compound |
| 09/30/2010 | WO2010110380A1 Fused piperidine compound and pharmaceutical agent comprising same |
| 09/30/2010 | WO2010110374A1 Agent for enhancing hypoglycemic activity |
| 09/30/2010 | WO2010110361A1 Method for producing bicyclic γ-amino acid derivative |
| 09/30/2010 | WO2010110353A1 Novel amide derivative and skin whitening agent |
| 09/30/2010 | WO2010110314A1 Therapeutic agent for pulmonary hypertension comprising nucleic acid |
| 09/30/2010 | WO2010110268A1 Pharmaceutical agent for preventing cell death |
| 09/30/2010 | WO2010110231A1 Substituted 3-hydroxy-4-pyridone derivative |
| 09/30/2010 | WO2010110045A1 Process for producing lactic acid bacterium having enhanced immunomodulating activity |
| 09/30/2010 | WO2010109736A1 Cartilage production promoter and prophylactic or therapeutic agent for diseases associated with cartilage damage |
| 09/30/2010 | WO2010109706A1 Therapeutic agent for cancer having reduced sensitivity to molecular targeted drug, and pharmaceutical composition for enhancing sensitivity to molecular targeted drug |
| 09/30/2010 | WO2010108314A1 Use of fiber pentose or composition containing fiber pentose in manufacture of foods or medicines for preventing and/or treating acidification in diabetic patient |
| 09/30/2010 | WO2010086746A3 Compositions and methods of treating viral infections |
| 09/30/2010 | US20100251393 Transgenic animals |
| 09/30/2010 | US20100249250 Reversible biogel for manipulation and separation of single-walled carbon nanotubes |
| 09/30/2010 | US20100249233 Compound and use thereof in the treatment of amyloidosis |
| 09/30/2010 | US20100249217 Modulators of pharmacological agents |
| 09/30/2010 | US20100249211 N-Substituted-Aminomethylene Bridged Bicyclic Nucleic Acid Analogs |
| 09/30/2010 | US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 09/30/2010 | US20100249160 Cancer Treatment Method |
| 09/30/2010 | US20100249159 Rho-kinase inhibitors |
| 09/30/2010 | US20100249072 Prodrugs and conjugates of prenylation inhibitors |
| 09/30/2010 | US20100249049 Arylalkylamine compound and process for preparing the same |
| 09/30/2010 | US20100248205 Reovirus Clearance of Ras-Mediated Neoplastic Cells from Mixed Cellular Compositions |
| 09/30/2010 | US20100247644 Adhesive compositions for the treatment of xerostomia |
| 09/30/2010 | US20100247633 Polypeptide Films and Methods |
| 09/30/2010 | US20100247529 Cooperative and dynamic assembly of affinity complexes |
| 09/30/2010 | US20100247446 Method and system for analyzing optical signal |
| 09/30/2010 | US20100247444 Compound, diagnostic agent, nuclear magnetic resonance analysis method, nuclear magnetic resonance imaging method, mass spectrometry method and mass spectrometry imaging method |
| 09/30/2010 | US20100247437 Materials and methods for the delivery of biomolecules to cells of an organ |
| 09/30/2010 | US20100247435 Measurement of neural activity |
| 09/30/2010 | CA2756750A1 A method for producing bicyclic .gamma.-amino acid derivative |
| 09/30/2010 | CA2756729A1 Method for producing lactic acid bacteria having enhanced immunoregulating activities |
| 09/30/2010 | CA2756428A1 Matrix-type sustained release preparation containing basic additive |
| 09/30/2010 | CA2754416A1 Novel medicament for treating cognitive impairment |
| 09/29/2010 | EP2233498A1 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same |
| 09/29/2010 | EP2233486A1 Azaindoles |
| 09/29/2010 | EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation. |
| 09/29/2010 | EP2233474A1 Condensed aminodihydrothiazine derivative |
| 09/29/2010 | EP2231157A1 Methods for increasing endothelial progentior cells |
| 09/29/2010 | EP2231156A1 Methods for increasing white blood cells |
| 09/29/2010 | EP1534695B1 Tyrosine kinase inhibitors |
| 09/29/2010 | EP1450847B1 APO2 ligand/ TRAIL formulations and uses thereof |
| 09/29/2010 | EP1446136B1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 09/29/2010 | EP1421074B1 Novel compounds |
| 09/29/2010 | EP1223956B1 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 09/29/2010 | EP1095274B1 Trifunctional reagent for conjugation to a biomolecule |
| 09/29/2010 | EP1086950B1 Heterocyclic indole derivatives and mono- or diazaindole derivatives |
| 09/29/2010 | CN1985855B Ginkgo health vinegar recipe and preparing method |
| 09/29/2010 | CN1984640B Topical antiviral formulations |
| 09/29/2010 | CN1679573B Implantable vascular device for delivery of topotecan in combination with rapamycin |
| 09/29/2010 | CN1674868B Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent |
| 09/29/2010 | CN101849014A Chimeric PUFA polyketide synthase systems and uses thereof |
| 09/29/2010 | CN101848932A Peptide having hypotensive activity |
| 09/29/2010 | CN101848926A Peptide capable of binding to immunoglobulin |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/29/2010 | CN101843653A Processing method of Chinese stellera root condensed decoction |
| 09/29/2010 | CN101843631A Application of baicalin in resisting and preventing bacterial infection |
| 09/29/2010 | CN101843610A Use of arachidonic acid for normalization of infradian rhythm |
| 09/29/2010 | CN101337931B Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 09/29/2010 | CN101293039B Compound essential oil for refreshing oneself, and eliminating fatigue |
| 09/29/2010 | CN101244229B Powder medicine for treating hernia |
| 09/29/2010 | CN101244225B Externally used medical ointment for regain consciousness, refrigerating and relieving summer-heat, and preparation thereof |
| 09/29/2010 | CN101130733B Wine capable of changing acidic constitution of human body |
| 09/28/2010 | USRE41783 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/28/2010 | US7803944 Viral polymerase inhibitors |
| 09/28/2010 | US7803939 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 09/28/2010 | US7803823 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases |
| 09/28/2010 | US7803811 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 09/28/2010 | US7803805 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents |
| 09/28/2010 | US7803774 retro-inverso isomers of beta-amyloid peptides, used for diagnosis and treatment of amyloidogenic diseases such as Alzheimer's disease |
| 09/28/2010 | US7803772 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity |
| 09/28/2010 | US7803766 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; long-acting action |
| 09/28/2010 | US7803749 Prevent signal transduction passageways; kinase inhibitor; modulate immunology response |
| 09/28/2010 | US7803739 Substrates and assays for β-secretase |
| 09/28/2010 | US7803618 nucleic acid encoding an anti-EpCAM protein; binds human epithelial cell adhesion molecule; immunoglobulin light chain region modified to reduce immunogenicity; diagnosis, prognosis and treatment of cancer |
| 09/28/2010 | US7803595 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/28/2010 | US7803562 Method for screening human intestinal Npt2B modulatory agents |
| 09/28/2010 | US7803560 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
| 09/28/2010 | US7803546 Method of screening for sensitivity to kinase inhibitor therapy |
| 09/28/2010 | US7803400 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances |
| 09/28/2010 | US7803373 Chemokine panec-1 antibodies |
| 09/28/2010 | US7803354 Cosmetic and/or dermatological use of a composition comprising at least one oxidation-sensitive hydrophilic active principle stabilized by at least one maleic anhydride copolymer |
| 09/28/2010 | CA2553160C 2-heteroaryl-substituted benzimidazole derivative |
| 09/28/2010 | CA2493765C Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 09/28/2010 | CA2480065C Injectable veterinary composition for small animals |
| 09/28/2010 | CA2459482C Novel glycolipid and medicine for autoimmune disease containing the same as active ingredient |